Updated New Zealand cardiovascular disease risk-benefit prediction guide.
作者信息
Jackson R
机构信息
Department of Community Health, University of Auckland, Auckland, New Zealand.
出版信息
BMJ. 2000 Mar 11;320(7236):709-10. doi: 10.1136/bmj.320.7236.709.
Abstract
摘要
相似文献
1
Updated New Zealand cardiovascular disease risk-benefit prediction guide.
BMJ. 2000 Mar 11;320(7236):709-10. doi: 10.1136/bmj.320.7236.709.
2
Risk in cardiovascular disease. Having so many different guidelines about reducing risk is confusing.
BMJ. 2000 Jul 15;321(7254):175.
3
Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculations.
BMJ. 2000 Jul 15;321(7254):174-5.
4
Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
Health Policy. 2017 Dec;121(12):1233-1239. doi: 10.1016/j.healthpol.2017.09.022. Epub 2017 Oct 10.
5
Risk assessment and management of cardiovascular disease in New Zealand.
N Z Med J. 2003 Nov 7;116(1185):U661.
6
Cardiovascular risk can be represented by scaled rectangle diagrams.
J Clin Epidemiol. 2009 Sep;62(9):998-1000. doi: 10.1016/j.jclinepi.2009.05.004.
7
Whither cardiovascular risk prediction?
Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):421-3. doi: 10.1097/01.hjr.0000186618.29992.f5.
8
Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors.
N Z Med J. 2003 Nov 7;116(1185):U663.
9
Cardiovascular risk assessment: audit findings from a nurse clinic--a quality improvement initiative.
J Prim Health Care. 2009 Sep;1(3):226-31.
10
引用本文的文献
1
The effectiveness of the chronic disease management for hypertension: A systematic review and meta-analysis.
Medicine (Baltimore). 2025 Jul 25;104(30):e42455. doi: 10.1097/MD.0000000000042455.
2
Contemporary Review of Risk Scores in Prediction of Coronary and Cardiovascular Deaths.
Curr Cardiol Rep. 2022 Jan;24(1):7-15. doi: 10.1007/s11886-021-01620-1. Epub 2022 Jan 27.
3
Predictive biomarkers of cardiovascular disease in adult Canadian population.
J Diabetes Metab Disord. 2021 Jul 17;20(2):1199-1209. doi: 10.1007/s40200-021-00842-y. eCollection 2021 Dec.
4
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice.
Front Cardiovasc Med. 2021 Oct 25;8:749686. doi: 10.3389/fcvm.2021.749686. eCollection 2021.
5
Cardiovascular Risk Estimates in Ten Years in the Brazilian Population, a Population-Based Study.
Arq Bras Cardiol. 2021 Mar;116(3):423-431. doi: 10.36660/abc.20190861.
6
GPs' familiarity with and use of cardiovascular clinical prediction rules: a UK survey study.
BJGP Open. 2020 Dec 15;4(5). doi: 10.3399/bjgpopen20X101081. Print 2020 Dec.
7
Cardiovascular disease risk perception in a Hungarian community sample: psychometric evaluation of the ABCD Risk Perception Questionnaire.
BMJ Open. 2020 Jul 13;10(7):e036028. doi: 10.1136/bmjopen-2019-036028.
8
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India.
BMC Public Health. 2018 Nov 15;18(1):1264. doi: 10.1186/s12889-018-6142-x.
9
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D.
Br J Clin Pharmacol. 2018 Oct;84(10):2194-2207. doi: 10.1111/bcp.13652. Epub 2018 Jul 17.
10
Association Between Work-Related Stress and Coronary Heart Disease: A Review of Prospective Studies Through the Job Strain, Effort-Reward Balance, and Organizational Justice Models.
J Am Heart Assoc. 2018 Apr 27;7(9):e008073. doi: 10.1161/JAHA.117.008073.
本文引用的文献
1
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.
JAMA. 1999;282(24):2340-6. doi: 10.1001/jama.282.24.2340.
2
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.
Lancet. 1996 Nov 16;348(9038):1339-42.
3
4
Hypertension in the elderly. Implications and generalizability of randomized trials.
JAMA. 1994 Dec 28;272(24):1932-8.
5
Cardiovascular disease risk profiles.
Am Heart J. 1991 Jan;121(1 Pt 2):293-8. doi: 10.1016/0002-8703(91)90861-b.
Zotero 插件